Photo of Ashlee Vivien Moses, Ph.D.

Ashlee Vivien Moses Ph.D.

    • Associate Professor RS.ORIO IBC
    • Molecular Microbiology and Immunology Graduate Program School of Medicine

Publications

  • "Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 from Associating with the Host Restriction Factor BST2/Tetherin." Journal of Infectious Diseases In: , Vol. 212, 01.10.2015, p. S181-S190.
  • "Kaposi sarcoma herpesvirus induces HO-1 during de novo infection of endothelial cells via viral miRNA-dependent and -independent mechanisms." mBio In: , Vol. 6, No. 3, 04.06.2015.
  • "CXCR7 expression disrupts endothelial cell homeostasis and causes ligand-dependent invasion." Cell Adhesion and Migration In: , Vol. 8, No. 2, 2014, p. 165-176.
  • "Comparative study of four immortalized human brain capillary endothelial cell lines, hCMEC/D3, hBMEC, TY10, and BB19, and optimization of culture conditions, for an in vitro blood-brain barrier model for drug permeability studies." Fluids and Barriers of the CNS  In: , Vol. 10, No. 1, 33, 22.11.2013.
  • "Aberrant Proliferation in CXCR7+ Endothelial Cells via Degradation of the Retinoblastoma Protein." PLoS One In: , Vol. 8, No. 7, e69828, 23.07.2013.
  • "A comparative mutational analysis of HIV-1 Vpu subtypes B and C for the identification of determinants required to counteract BST-2/Tetherin and enhance viral egress." Virology In: , Vol. 441, No. 2, 05.07.2013, p. 182-196.
  • "Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses." Current Opinion in Virology  In: , Vol. 3, No. 3, 06.2013, p. 285-295.
  • "IRF-3, IRF-5, and IRF-7 Coordinately Regulate the Type I IFN Response in Myeloid Dendritic Cells Downstream of MAVS Signaling." PLoS Pathogens In: , Vol. 9, No. 1, e1003118, 01.2013.
  • "CD31 immunohistochemical staining in kaposi sarcoma." Archives of Pathology and Laboratory Medicine  In: , Vol. 136, No. 11, 11.2012, p. 1329.
  • "Ubiquitination of BST-2 protein by HIV-1 Vpu protein does not require lysine, serine, or threonine residues within the BST-2 cytoplasmic domain." Journal of Biological Chemistry In: , Vol. 287, No. 18, 27.04.2012, p. 14837-14850.
  • "Kaposi's sarcoma and human dermal microvascular endothelial cells infected with Kaposi's sarcoma-associated herpesvirus express CCL21." Journal of Dermatological Science  In: , Vol. 61, No. 2, 02.2011, p. 139-142.
  • "Viral takeover of the host ubiquitin system." Frontiers in Microbiology In: , Vol. 2, No. JULY, 2011.
  • "The great escape : Viral strategies to counter BST-2/ tetherin." PLoS Pathogens  In: , Vol. 6, No. 5, 05.2010, p. 1-12.
  • "Targeting signal transduction pathways for the treatment of Kaposi sarcoma."  Molecular Basis for Therapy of AIDS-Defining Cancers. Springer New York, 2010. p. 79-93.
  • "Kaposi sarcoma pathogenesis : A triad of viral infection, oncogenesis and chronic inflammation." Translational Biomedicine  In: , Vol. 1, No. 2, 2, 2010.
  • "The inflammatory component of Kaposi sarcoma." Experimental and Molecular Pathology In: , Vol. 87, No. 2, 10.2009, p. 163-165.
  • "Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus." Journal of Virology  In: , Vol. 83, No. 19, 10.2009, p. 9672-9681.
  • "Characterization of c-Kit expression and activation in KSHV-infected endothelial cells." Virology In: , Vol. 390, No. 2, 01.08.2009, p. 174-185.
  • "Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/tetherin via a βTrCP-dependent mechanism." Journal of Virology In: , Vol. 83, No. 16, 08.2009, p. 7931-7947.
  • "Remodeling of endothelial adherens junctions by Kaposi's sarcoma-associated herpesvirus." Journal of Virology  In: , Vol. 82, No. 19, 10.2008, p. 9615-9628.
  • "Human cytomegalovirus secretome contains factors that induce angiogenesis and wound healing." Journal of Virology In: , Vol. 82, No. 13, 07.2008, p. 6524-6535.
  • "The role of angiogenic and wound repair factors during CMV-accelerated transplant vascular sclerosis in rat cardiac transplants." American Journal of Transplantation In: , Vol. 8, No. 2, 02.2008, p. 277-287.
  • "Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma [8]." British Journal of Ophthalmology In: , Vol. 92, No. 2, 02.2008, p. 297-299.
  • "Pathology of rituximab-induced Kaposi sarcoma flare." BMC Clinical Pathology In: , Vol. 8, No. 1, 7, 2008.
  • "Mechanisms of cytomegalovirus-accelerated vascular disease : Induction of paracrine factors that promote angiogenesis and wound healing." Current Topics in Microbiology and Immunology In: , Vol. 325, 2008, p. 397-415.
  • "Kaposi's sarcoma : A model of both malignancy and chronic inflammation." Panminerva Medica In: , Vol. 49, No. 3, 09.2007, p. 119-138.
  • "Insulin-like growth factor II receptor-mediated intracellular retention of cathepsin B is essential for transformation of endothelial cells by Kaposi's sarcoma-associated herpesvirus." Journal of Virology  In: , Vol. 81, No. 15, 08.2007, p. 8050-8062.
  • "The insulin receptor is essential for virus-induced tumorigenesis of Kaposi's sarcoma." Oncogene In: , Vol. 26, No. 14, 29.03.2007, p. 1995-2005.
  • "Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology." Current Topics in Microbiology and Immunology In: , Vol. 312, 2007, p. 211-244.
  • "Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells." Blood  In: , Vol. 108, No. 6, 15.09.2006, p. 1932-1940.

Additional information

Edit profile